GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Krebs Biochemicals & Industries Ltd (BOM:524518) » Definitions » Valuation Rank

Krebs Biochemicals & Industries (BOM:524518) Valuation Rank


View and export this data going back to 2000. Start your Free Trial

What is Krebs Biochemicals & Industries Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Krebs Biochemicals & Industries Valuation Rank Related Terms

Thank you for viewing the detailed overview of Krebs Biochemicals & Industries's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Krebs Biochemicals & Industries (BOM:524518) Business Description

Traded in Other Exchanges
Address
Road No. 8, Banjara Hills, 8-2-577/B, Plot No. 34, 3rd Floor, Maas Heights, Hyderabad, TG, IND, 500 034
Krebs Biochemicals & Industries Ltd is a biochemical company in India. It is engaged in the business of manufacture of active pharmaceutical ingredients. It has two manufacturing plants in Andhra Pradesh, India - one in Nellore and one in Vizag both Units are equipped for chemical synthesis, fermentation, and enzymatic technologies providing Krebs with production capacity.